Biography

Anjana Aravind

Ph.D.

Assistant Professor I

Dr. Anjana Aravind obtained her Ph.D. from Yenepoya (Deemed to be University), where
her doctoral research focused on developing a mass spectrometry-based multi-protein panel
assay for the detection of immunotherapeutic targets in cancer patients. She qualified CSIR-
JRF-NET and completed her doctoral research work at the Yenepoya Research Centre.
During her Ph.D., Dr. Aravind conducted extensive proteomic analyses of immune cells
derived from cancer patients, with a particular emphasis on cancer-related signaling pathways
and immunoregulatory biomarker panels. Her research expertise includes global proteomics,
phosphoproteomics, and targeted mass spectrometry–based approaches. Her research
interests lie in immune cell proteomics and advanced proteomic strategies to investigate
immunoregulation and signaling networks, with a special focus on immune checkpoint
mechanisms. She is also an inventor on two patents: the first describes a mass
spectrometry–based assay developed to detect an immune checkpoint protein panel from
immune cells and tumor samples of cancer patients, while the second relates to a mass
spectrometry approach for detecting ESR1 protein mutations in FFPE samples from breast
cancer patients. Dr. Aravind has authored several peer-reviewed research articles published in
high-impact journals, including Journal of Proteome Research, Frontiers in Immunology,
Journal of Cell Communication and Signaling, Molecular Omics, and Molecular & Cellular
Proteomics.

Center for Systems Biology and Molecular Medicine

An ICMR collaborating centre of excellence (ICMR-CCoE)

Biography

Anjana Aravind

Publications